![Jamie Oliver](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jamie Oliver
Direttore/Membro del Consiglio presso Elion Oncology, Inc.
Provenienza dei contatti di primo grado di Jamie Oliver
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Elion Oncology, Inc.
![]() Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Elion Oncology, Inc. engages in the provision of pharmaceutical services. The company was founded in 2016 and is headquartered in Bethesda, MD.
1
| Private Company | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jamie Oliver tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
UCSD Medical Center
![]() UCSD Medical Center Medical/Nursing ServicesHealth Services UCSD Medical Center provides medical services to its clients. The medical center is a part of University of California, San Diego. UCSD Medical Center's facilities consist of UCSD Thornton Hospital in La Jolla, UCSD Medical Center in Hillcrest, and several specialty outpatient clinics and ambulatory health facilities throughout the area. The services provided by the medical center and its affiliates include general medicine and primary care, women's health services, and emergency care for the treatment of serious conditions. The company is headquartered in San Diego, CA | Medical/Nursing Services | Corporate Officer/Principal | |
TiVenture SA
![]() TiVenture SA Investment ManagersFinance TiVenture SA is a venture capital fund with headquarters in Lugano, Switzerland. The firm was founded in 2012. | Investment Managers | Private Equity Investor | |
GT Gain Therapeutics SA
![]() GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
GAIN THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Svizzera | 5 |
Stati Uniti | 4 |
Settori
Health Technology | 6 |
Health Services | 2 |
Finance | 2 |
Posizioni
Founder | 4 |
Chief Tech/Sci/R&D Officer | 2 |
Private Equity Investor | 2 |
Director/Board Member | 2 |
President | 1 |
Contatti più connessi
Insiders | |
---|---|
Lorenzo Leoni | 9 |
- Borsa valori
- Insiders
- Jamie Oliver
- Connessioni Società